The Asia Pacific Liver Health Supplements Market would witness market growth of 5.04% CAGR during the forecast period (2019-2025).
Asia-Pacific attained a dominant market share and the region has also been estimated to remain dominant over the forecast period. Some of the key factors contributing to this growth include growing incomes, increased prevalence of digestive tract diseases, and increasing awareness of organic process products are some of the factors that contribute to regional growth.
In addition, the rising standard of personalized nutrition among shoppers is expected to lead to regional growth for liver health supplements. The growth rate can be associated with the increased prevalence of various diseases of the digestive tract, rising incomes and increased awareness of high nutritional ingredients in health products. In addition, the growing standard of personalized nutrition among people in the region is another significant factor.
The liver absorbs and breaks down all of the toxins found in the body to flush them out of the body. The health of the liver and its functionality is important for functioning the body healthily. Chronic liver disorders such as liver cirrhosis, liver hepatitis, non-alcoholic fatty liver diseases, etc. are prevalent because of reduced food quality, increased fast food and alcohol intake worldwide. Among all health supplements, the rate of growth in the consumption of liver health supplements has been demonstrating an increasing trend in recent years. Liver health supplements are available in the form of tablet, powder, liquid and soft gels.
Based on Form, the market is segmented into Capsules, Liquids, Tablets, Powders and Other Forms. Based on Product, the market is segmented into Herbal Supplements, Vitamins & Minerals and Other Products. The report also covers geographical segmentation of Liver Health Supplements market. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Australia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include The Nature’s Bounty Co. (The Carlyle Group L.P.), The Himalaya Drug Company (Himalaya Global Holdings Ltd.), NOW Foods, Inc., Integria Healthcare (Australia) Pty Ltd., Enzymedica, Inc., Jarrow Formulas, Inc., Irwin Naturals, Inc., Gaia Herbs, Inc., Swanson Health Products, Inc. (Swander Pace Capital), and Nature’s Way Products LLC (Dr. Willmar Schwabe GmbH & Co. KG).
Scope of the Study
• Powders and
• Other Forms
• Herbal Supplements
• Vitamins & Minerals and
• Other Products
• South Korea
• Rest of Asia Pacific
• The Nature’s Bounty Co. (The Carlyle Group L.P.)
• The Himalaya Drug Company (Himalaya Global Holdings Ltd.)
• NOW Foods, Inc.
• Integria Healthcare (Australia) Pty Ltd.
• Enzymedica, Inc.
• Jarrow Formulas, Inc.
• Irwin Naturals, Inc.
• Gaia Herbs, Inc.
• Swanson Health Products, Inc. (Swander Pace Capital)
• Nature’s Way Products LLC (Dr. Willmar Schwabe GmbH & Co. KG)
• Exhaustive coverage
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free
Our reports have been used by over 10K customers, including:
Non Alcoholic Fatty Liver Disease (NAFLD) (Gastrointestinal) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Non Alcoholic Fatty Liver Disease - Drugs in Development, 2021, provides an overview of the Non Alcoholic Fatty Liver Disease (Gastrointestinal)...
200 pages •
By The Business Research Company
• Mar 2021
Major players in the ultra-low temperature freezers market are Arctiko, Eppendorf, Esco Micro Pte Ltd, Haier, Helmer Scientific, Bionics Scientific Technologies (P). Ltd, PHC Holdings Corporation, Labcold Ltd, Remi Group, and Stirling Ultracold. The global ultra-low temperature freezers market is expected to decline from $633.94 million...
The global immunofluorescence assays market is projected to reach USD 3.5 billion by 2026 from USD 2.6 billion in 2021, at a CAGR of 6.0% during the forecast period. The growth in this market is primarily attributed to the increasing prevalence of chronic diseases and rising R&D spending & healthcare expenditure. Emerging markets are expected...
The Asia Pacific organoids market is expected to reach US$ 513.74 million in 2027 from US$ 97.02 million in 2019. The market is estimated to grow at a CAGR of 23.1% from 2020 to 2027. Rising adoption of biobanking and tumor modelling and alternatives for animal testing models acting as kingpins are expected to augment the growth of the...
The global organoids market is expected to reach US$ 3,420.40 million by 2027 from US$ 689.47 million in 2019. The market is estimated to grow at a CAGR of 22.1% from 2020 to 2027. Increasing demand for tumor modelling and biobanking, rising adoption of personalized drugs, and growing focus on developing alternatives for animal testing...
Preventative measures: The availability of and demand for pathology tests has boosted revenue Abstract Pathology Services in Australia Industry players operate pathology laboratories and collection centres. Pathology services that are provided by public laboratories operating within general hospitals...
An organ-on-a-chip is a microfluidic cell culture device that contains continuously perfused chambers. This chip develops a narrow channel for the blood and airflow in organs, such as the lung, gut, liver, heart, and other organs. Such devices produce multiple levels of tissue and organ functionalities, which are not feasible using conventional...
Melanoma - Global Drug Forecast and Market Analysis to 2029
Melanoma of the skin is a serious and aggressive form of cancer originating from melanocytes, the pigment cells in skin, and can develop anywhere on the body.Although melanoma has high survivability, it remains a significant health...
The Asia Pacific Surgical Robotic Systems Market would witness market growth of 22.8% CAGR during the forecast period (2020-2026). Key components ascribing to the development includes expanding adoption of minimally invasive surgeries among patients due to its additional advantages, for example, the requirement for shorter stays in...
The Global Medical Thermometer Market size is expected to reach $972.7 Million by 2026, rising at a market growth of 6.5% CAGR during the forecast period. A thermometer is a medical device that is used to measure body temperature. The rise in the cases of influenza, norovirus, COVID-19, and other medical conditions as well as increasing awareness...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.